Select Publications

Conference Abstracts

Dolnikov A; Xu N; Tse B; Shen S; O'Brien T, 2018, 'BROMODOMAIN INHIBITOR JQ1 MODULATES IMMUNE SUPPRESSIVE PATHWAYS IN NEUROBLASTOMA AND ENHANCES CARGD2T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Xu N; Tse B; O'Brien T, 2018, 'EPIGENETIC AGENT MODULATES TUMOUR MICROENVIRONMENT AND POTENTIATES CART CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Xu N; Tse B; Bishop D; Gottlieb D; Micklethwaite K; O'Brien T, 2018, 'FACTORS PROMOTING CD19-NEGATIVE RELAPSES FOLLOWING CAR19T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S8 - S8, http://dx.doi.org/10.1016/j.jcyt.2018.02.009

Chaudhry K; Shen S; Wang L; Bishop D; Micklethwaite K; Dolnikov A; Nordon R, 2018, 'IMAGING THE DYNAMICS OF RECEPTOR-MODIFIED T CELL EFFECTOR FUNCTION AGAINST LEUKAEMIA AND NEUROBLASTOMA TARGETS', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S103 - S103, http://dx.doi.org/10.1016/j.jcyt.2018.02.301

Tse B; Xu N; Bishop D; Gottlieb D; Micklethwaite K; O'Brien T; Dolnikov A, 2018, 'TUMOUR MICROENVIRONMENT MODULATES CART CELL FATE IN PAEDIATRIC LEUKEMIA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, http://dx.doi.org/10.1016/j.jcyt.2018.02.286

Bishop D; Xu N; Shen S; O'Brien T; Gottlieb D; Dolnikov A; Micklethwaite K, 2017, 'DIFFERING CO-STIMULATORY, LINKER AND SPACER DOMAINS PRODUCE VARIATIONS IN CD4 AND CD8 CELL COMPOSITION AND CYTOTOXIC POTENTIAL IN CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR19) T CELLS GENERATED WITH THE PIGGYBAC TRANSPOSASE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 19, pp. S10 - S10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399265400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Yang S; Shen S; Xu N; Chaudhry K; Nordon R; O'Brien T, 2016, 'PROLONGING CART CELL PERSISTENCE USING CONDITIONING WITH 5-AZACYTIDINE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S61 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen S; Xu N; Yang S; O'Brien T; Dolnikov A, 2016, 'STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS TO TREAT CANCER', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen S; Dolnikov A; O'Brien T, 2016, 'USE OF HDACI AND PD-1/PD-LI BLOCKADE TO ENHANCE CYTOLYTIC ACTIVITY OF EX VIVO EXPANDED NK CELLS AGAINST NEUROBLASTOMA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Klamer G; Chitranjan A; Xu N; Shen S; Micklethwaite KP; Lock RB; O'Brien T, 2014, 'Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy', in BLOOD, AMER SOC HEMATOLOGY, Vol. 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349242706217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Klamer G; Shen S; Chitranjan A; Carol H; Lock R; O'Brien T, 2014, 'IDENTIFYING THE FACTORS MODULATING THE EFFICACY OF CAR-T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 16, pp. S7 - S7, http://dx.doi.org/10.1016/j.jcyt.2014.01.015

Ko KH; Holmes T; Song EY; Palladinetti P; Nordon R; O'Brien TA; Dolnikov A, 2010, 'GSK-3BETA INHIBITION PROMOTES ENGRAFTMENT OF EX VIVO EXPANDED HEMATOPOIETIC STEM CELLS AND MODULATES GENE EXPRESSION', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, Vol. 38, pp. S52 - S52, presented at 39th Annual Scientific Meeting of the ISEH - Society-for-Hematology-and-Stem-Cells, AUSTRALIA, Melbourne, 15 September 2010 - 18 September 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281168900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page